Keywords: xenova, says, lead, drug, track, phase, iii

Xenova says lead drug on track for Phase III

Article | 20 May 2002

Print This

Xenova of the UK has confirmed that its lead drug candidate, Tariquidar(XR9576), is on track to enter a pivotal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in